Emma van Groesen

Emma van Groesen is a Scientist in Bioanalytical Sciences at Genmab since June 2022, leading the development, qualification, validation, and execution of ligand binding assays for pharmacokinetic and anti-drug antibody measurements in a regulated GLP/GCP environment. Prior to this, Emma completed a PhD in Biological Chemistry at Universiteit Leiden, focusing on novel glycopeptide antibiotics, which included organic synthesis and biochemical activity assessments. Experience also includes research internships at the University of Oxford, Utrecht University, and a Master of Science in Drug Innovation from Utrecht University. Emma also holds a Bachelor of Science in Pharmaceutical Sciences and a High School Diploma from Odulphuslyceum.